Keeps Biopharma Inc. (KOSDAQ:256940)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,500
+10 (0.10%)
At close: Oct 2, 2025

Keeps Biopharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-1,2411,1133,930-11,375-15,317-2,406
Upgrade
Depreciation & Amortization
2,9812,5821,442993.33812.4604.28
Upgrade
Loss (Gain) From Sale of Assets
0.99-24.1577.46-52.48-19.1582.9
Upgrade
Asset Writedown & Restructuring Costs
383.84383.84----
Upgrade
Loss (Gain) From Sale of Investments
-102.09-847.49-1,077177.952,519-2,871
Upgrade
Loss (Gain) on Equity Investments
1,3731,609-4,9303,9983,0812,184
Upgrade
Stock-Based Compensation
--269.1509.971,45859.53
Upgrade
Provision & Write-off of Bad Debts
679.29-1,34370.84912.842,926139.34
Upgrade
Other Operating Activities
-3,3105,2585,255565.12-2,0732,959
Upgrade
Change in Accounts Receivable
4.53-963.41-622.46561.76-1,447-4,193
Upgrade
Change in Inventory
-4,429-4,816-696.770.6-1,9973,150
Upgrade
Change in Accounts Payable
-1,789-1,0901,224-138.22611.5-647.04
Upgrade
Change in Other Net Operating Assets
940.842,945-4,9992,9801,066-798.88
Upgrade
Operating Cash Flow
-4,5074,808-57.13-866.26-8,380-1,737
Upgrade
Capital Expenditures
-8,350-6,596-990.97-95.85-90.75-1,043
Upgrade
Sale of Property, Plant & Equipment
-945.1227.1824.1830.3138.3177.47
Upgrade
Cash Acquisitions
-25,605-17,812-26,610---
Upgrade
Sale (Purchase) of Intangibles
-2,500-104.49-79.79-33.96-32.2-649.38
Upgrade
Investment in Securities
3,930100.66682.22-3,199-11,484-5,094
Upgrade
Other Investing Activities
230.73456.64992.3-4,784-88.42-27.79
Upgrade
Investing Cash Flow
-33,727-22,275-27,591-9,427-14,276-9,531
Upgrade
Short-Term Debt Issued
-50019,000-3,00014,000
Upgrade
Long-Term Debt Issued
-12,0123,000-32,00028,000
Upgrade
Total Debt Issued
53,61912,51222,000-35,00042,000
Upgrade
Short-Term Debt Repaid
--6,000-13,000--7,000-10,000
Upgrade
Long-Term Debt Repaid
--6,234-248.51-3,327-330.69-620.41
Upgrade
Total Debt Repaid
-4,920-12,233-13,249-3,327-7,331-10,620
Upgrade
Net Debt Issued (Repaid)
48,699278.158,751-3,32727,66931,380
Upgrade
Issuance of Common Stock
1,199--353.55398.186,133
Upgrade
Other Financing Activities
7,14331,649-600-298-35.681,178
Upgrade
Financing Cash Flow
57,04031,9278,151-3,27228,03238,690
Upgrade
Foreign Exchange Rate Adjustments
78.1210.67-21.75-6.82673.45-677.29
Upgrade
Net Cash Flow
18,88514,671-19,519-13,5726,04926,744
Upgrade
Free Cash Flow
-12,857-1,787-1,048-962.12-8,471-2,780
Upgrade
Free Cash Flow Margin
-8.67%-1.40%-1.14%-6.58%-198.82%-18.27%
Upgrade
Free Cash Flow Per Share
-678.51-94.64-55.71-51.34-489.19-189.82
Upgrade
Cash Interest Paid
1,5101,3261,360-79.71153.18
Upgrade
Cash Income Tax Paid
2,34113.8514.57137.2843.29-3.69
Upgrade
Levered Free Cash Flow
-12,86621,084-12,42323.1-9,364-7,098
Upgrade
Unlevered Free Cash Flow
-9,30623,416-11,154607.29-8,308-6,057
Upgrade
Change in Working Capital
-5,273-3,924-5,0953,405-1,766-2,489
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.